Investigation of Tumor-derived Extracellular DNA in Blood of Cancer Patients by Methylation-specific PCR
Overview
Authors
Affiliations
The frequency of APC, RASSF1A, RARbeta, CDH1 and CDH13 gene promoter methylation in samples of DNA isolated from breast and lung patient plasma was studied in order to develop the noninvasive tumor-specific DNA detection method. Methylation of at least one of genes was detected in extracellular DNA from most of the cancer blood specimens. The results obtained indicate that promoter hypermethylation of a number of marker genes represents a promising serum marker for early breast and lung cancer detection.
Applying circulating tumor DNA methylation in the diagnosis of lung cancer.
Li L, Fu K, Zhou W, Snyder M Precis Clin Med. 2022; 2(1):45-56.
PMID: 35694699 PMC: 8985769. DOI: 10.1093/pcmedi/pbz003.
APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis.
Liu F, Lu X, Zhou X, Huang H Thorac Cancer. 2021; 12(21):2907-2913.
PMID: 34545707 PMC: 8563159. DOI: 10.1111/1759-7714.14151.
Sampling, Logistics, and Analytics of Urine for RT-qPCR-based Diagnostics.
Kretschmer-Kazemi Far R, Frank K, Sczakiel G Cancers (Basel). 2021; 13(17).
PMID: 34503191 PMC: 8430584. DOI: 10.3390/cancers13174381.
Hypermethylation of the promoter leads to low expression in early-stage non-small cell lung cancer.
Tan X, Zhang S, Gao H, He W, Xu M, Wu Q Oncol Lett. 2019; 18(2):1278-1286.
PMID: 31423188 PMC: 6607221. DOI: 10.3892/ol.2019.10400.
Qian X, Ruan L Thorac Cancer. 2018; 9(2):284-290.
PMID: 29297603 PMC: 5792726. DOI: 10.1111/1759-7714.12580.